We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Center Dedicated to Cancer Molecular Imaging

By HospiMedica staff writers
Posted on 12 Oct 2006
A new center will work to improve traditional cancer-detection methods by identifying cancer-specific genes that are ideally suited for molecular imaging and diagnosis.

Case Western Reserve University School of Medicine (Cleveland, OH, USA) and the U.S. More...
National Foundation for Cancer Research (NFCR, Bethesda, MD, USA) have announced the establishment of the new NFCR Center for Molecular Imaging. This center, funded by a five-year grant from the NFCR, will be led by James P. Basilion, Ph.D., associate professor of radiology and biomedical engineering at Case Schools of Medicine and Engineering. It will focus on assisting cancer scientists to identify specific genes that are ideally suited for molecular imaging and improved diagnosis that will lead to earlier-stage treatments for cancer patients.

Research has consistently shown that the earlier a physician can diagnose a tumor, the greater the chance of effectively treating the patient against cancer and increasing the chance of survival. "Molecular imaging is being recognized as the next revolution in cancer research and is paving the way for patient-specific imaging evaluation based on molecular and genetic markers” said Dr. Basilion.

Current traditional cancer-detection methods such as magnetic resonance imaging (MRI) and ultrasound are not effective for detecting small, newly formed tumors in patients. At the new center, scientists will develop methods that will more accurately predict how a patient will respond to certain chemotherapy drugs based on the diagnosis. These methods check the production level of a group of cancer-related genes inside the patient's body and help doctors to determine more accurately what therapy should be given.



Related Links:
Case Western Reserve University School of Medicine
National Foundation for Cancer Research

New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.